Direkt zum Inhalt
Merck

Four types of fatty acids exert differential impact on pancreatic cancer growth.

Cancer letters (2015-02-14)
Ming Yu, Hongyi Liu, Yijie Duan, Dapeng Zhang, Shasha Li, Feng Wang
ZUSAMMENFASSUNG

Increased fatty acids (FAs) regulate pancreatic cancer progression, however, the detailed mechanism is not clear, and different forms of FAs may play diversified roles in pancreatic cancer. To elucidate the underlying mechanism, we compared the effects of four major types of FAs on pancreatic cancer growth both in cell culture and in a mouse model. HPAF pancreatic cancer cells were implanted in nude mice for 14 weeks, and the mice were fed with four different high-fat/high-energy diets (15% fat, 4 kcal/g), an iso-caloric diet (5% fat, 4 kcal/g) and a normal diet (4% fat, 3 kcal/g). The high fat diets were rich in saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and n-6 and n-3 polyunsaturated fatty acids (n6- and n3PUFAs), respectively. While n3PUFA diet decreased tumor viability, the other high fat diets stimulated tumor viability by apparently different mechanisms. For instance, xenografts whose carriers were fed with SFA diet had marked expression of cancer-related proteins and lipid droplets. Although mice that were fed with MUFA- and n6PUFA diets had pancreatic tumors of similar size, liver metastasis occurred more frequently in those with the n6PUFA diet. In experiments in vitro, the HPAF-cell population was increased by SFAs and MUFAs, decreased by n3PUFAs and not changed by n6PUFAs. In conclusion, different fatty acids have different impact on pancreatic cancer cells. The effects of fatty acids on pancreatic cancer cells were consistent in vivo and in vitro except that n6PUFAs only had regulatory effects in vivo.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Oleinsäure, technical grade, 90%
Sigma-Aldrich
Palmitinsäure, ≥99%
Sigma-Aldrich
α-Linoleic acid, ≥98%
Sigma-Aldrich
Linolensäure, ≥99%
Sigma-Aldrich
Oleinsäure, ≥99% (GC)
Sigma-Aldrich
Oleinsäure, suitable for cell culture, BioReagent
Sigma-Aldrich
(L)-Dehydroascorbinsäure
Sigma-Aldrich
Laurinsäure, ≥98%, FCC, FG
Sigma-Aldrich
Linolsäure, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
Palmitoleinsäure, ≥98.5% (GC), liquid
Sigma-Aldrich
Palmitinsäure, BioXtra, ≥99%
Sigma-Aldrich
Arachidonsäure, >95.0% (GC)
Sigma-Aldrich
Oleinsäure, natural, FCC
Sigma-Aldrich
Oleinsäure, meets analytical specification of Ph, Eur., 65.0-88.0% (GC)
Supelco
Palmitinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Arachidonsäure, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
Laurinsäure, 98%
Sigma-Aldrich
Palmitinsäure, ≥98%, FCC, FG
USP
Palmitinsäure, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Linolsäure, technical, 58-74% (GC)
Supelco
Oleinsäure, analytical standard
Supelco
Linolsäure, analytical standard
Supelco
Palmitinsäure, analytical standard
Sigma-Aldrich
Laurinsäure, natural, ≥98%, FCC, FG
Sigma-Aldrich
Dodecansäure, ≥99% (GC/titration)
Supelco
Linolensäure, analytical standard
Sigma-Aldrich
Palmitinsäure, ≥98% palmitic acid basis (GC)
Supelco
Palmitoleinsäure, analytical standard
Sigma-Aldrich
Linolensäure, ~70% (GC)
Palmitinsäure, European Pharmacopoeia (EP) Reference Standard